Rapid development resistance antifolates vitro possible clinical implication incubation periods methotrexate MTX trimetrexate TMTX human colon adenocarcinoma cells high levels resistance drugs increases median effective doses short-term exposures hours drugs high degree resistance cells treatment cycles MTX TMTX onset resistance antimetabolites cells strategy results MTX TMTX mice murine leukemia cells cells resistant short-term exposure MTX cross-resistant drug days cells MTX days cross-resistant drug hours Analogous results TMTX circumstances schedule administration agent resistance clinical relevance data adjuvant chemotherapy loco-regional continuous-infusion chemotherapy 